Power Law company profile

Xeris Pharmaceuticals

Biotech & Life Sciences · Chicago, United States · Founded 2005 · IPO 2018 Unicorn

Pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables

Valuation

$1.20B

Market cap · May/2026

Revenue

$292M

Latest reported FY

EBITDA

$42M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

3 investors on Xeris Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Central Texas Angel Network

Series B+ 2 investors entered at this stage

Texas Venture Labs

Redmile Group

Global footprint

Where Xeris Pharmaceuticals has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States99.4%

🇦🇷 Argentina0.3%

🇮🇪 Ireland0.3%

3 countries shown

Web traffic by country

15K monthly visits
across markets

🇺🇸 United States71.3%

🇦🇺 Australia10%

🇮🇳 India8.7%

🇬🇧 United Kingdom6%

🇨🇦 Canada4.7%

Top 5 markets shown

Patent intelligence

$39M patent portfolio · 25 active families

Estimated portfolio value

$39M

3.3% of market cap · 13.3× smaller than top peer ChemoCentryx ($524M)

25 active patent families

Where Xeris Pharmaceuticals innovates DiseaseCancerIsotonic SolutionsAcromegalyHormones regulation

Where Xeris Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Xeris Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Xeris Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Xeris Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xeris Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles